|
1
|
Felice KM, Salzman DW, Shubert-Coleman J,
Jensen KP and Furneaux HM: The 5′ terminal uracil of let-7a is
critical for the recruitment of mRNA to Argonaute2. Biochem J.
422:329–341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jonas S and Izaurralde E: Towards a
molecular understanding of microRNA-mediated gene silencing. Nat
Rev Genet. 16:421–433. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iorio MV and Croce CM: microRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Corvalan AH and Maturana MJ: Recent
patents of DNA methylation biomarkers in gastrointestinal oncology.
Recent Pat DNA Gene Seq. 4:202–209. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Felicetti F, Errico MC, Segnalini P,
Mattia G and Carè A: MicroRNA-221 and -222 pathway controls
melanoma progression. Expert Rev Anticancer Ther. 8:1759–1765.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang YW and Chen LA: microRNAs as tumor
inhibitors, oncogenes, biomarkers for drug efficacy and outcome
predictors in lung cancer (Review). Mol Med Rep. 5:890–894.
2012.PubMed/NCBI
|
|
7
|
Reid DJ and Pham NT: Emerging Therapeutic
Options for the Management of COPD. Clin Med Insights Circ Respir
Pulm Med. 7:7–15. 2013.PubMed/NCBI
|
|
8
|
Lococo F, Cesario A, Del Bufalo A,
Ciarrocchi A, Prinzi G, Mina M, Bonassi S and Russo P: Novel
therapeutic strategy in the management of COPD: A systems medicine
approach. Curr Med Chem. 22:3655–3675. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang M, Huang Y, Liang Z, Liu D, Lu Y, Dai
Y, Feng G and Wang C: Plasma miRNAs may be promising biomarkers of
chronic obstructive pulmonary disease. Clin Respir J. 10:104–111.
2014. View Article : Google Scholar
|
|
10
|
Navratilova Z, Kolek V and Petrek M:
Matrix metalloproteinases and their inhibitors in chronic
obstructive pulmonary disease. Arch Immunol Ther Exp (Warsz).
64:177–193. 2015. View Article : Google Scholar
|
|
11
|
Zanette DL, Rivadavia F, Molfetta GA,
Barbuzano FG, Proto-Siqueira R, Silva-Jr WA, Falcão RP and Zago MA:
miRNA expression profiles in chronic lymphocytic and acute
lymphocytic leukemia. Braz J Med Biol Res. 40:1435–1440. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xi S, Yang M, Tao Y, Xu H, Shan J,
Inchauste S, Zhang M, Mercedes L, Hong JA, Rao M, et al: Cigarette
smoke induces C/EBP-β-mediated activation of miR-31 in normal human
respiratory epithelia and lung cancer cells. PLoS One.
5:e137642010. View Article : Google Scholar
|
|
13
|
Huleihel L, Ben-Yehudah A, Milosevic J, Yu
G, Pandit K, Sakamoto K, Yousef H, LeJeune M, Coon TA, Redinger CJ,
et al: Let-7d microRNA affects mesenchymal phenotypic properties of
lung fibroblasts. Am J Physiol Lung Cell Mol Physiol.
306:L534–L542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Van Pottelberge GR, Mestdagh P, Bracke KR,
Thas O, van Durme YM, Joos GF, Vandesompele J and Brusselle GG:
MicroRNA expression in induced sputum of smokers and patients with
chronic obstructive pulmonary disease. Am J Respir Crit Care Med.
183:898–906. 2011. View Article : Google Scholar
|
|
15
|
Mizuno S, Bogaard HJ, Gomez-Arroyo J,
Alhussaini A, Kraskauskas D, Cool CD and Voelkel NF:
MicroRNA-199a-5p is associated with hypoxia-inducible factor-1α
expression in lungs from patients with COPD. Chest. 142:663–672.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu DD, Tang RN, Lv LL, Wen Y, Liu H,
Zhang XL, Ma KL and Liu BC: Interleukin-1β mediates high glucose
induced phenotypic transition in human aortic endothelial cells.
Cardiovasc Diabetol. 15:422016. View Article : Google Scholar
|
|
17
|
Liu Y, Pleasants RA, Croft JB, Wheaton AG,
Heidari K, Malarcher AM, Ohar JA, Kraft M, Mannino DM and Strange
C: Smoking duration, respiratory symptoms, and COPD in adults aged
≥45 years with a smoking history. Int J Chron Obstruct Pulmon Dis.
10:1409–1416. 2015. View Article : Google Scholar :
|
|
18
|
Johar D, Siragam V, Mahood TH and Keijzer
R: New insights into lung development and diseases: The role of
microRNAs. Biochem Cell Biol. 93:139–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma J, Hong L, Xu G, Hao J, Wang R, Guo H,
Liu J, Zhang Y, Nie Y and Fan D: miR-483-3p plays an oncogenic role
in esophageal squamous cell carcinoma by targeting tumor suppressor
EI24. Cell Biol Int. 40:448–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiao Y, Zhao Y, Liu Y, Ma N, Wang C, Zou
J, Liu Z, Zhou Z, Han D, He J, et al: miR-483-3p regulates
hyperglycaemia-induced cardiomyocyte apoptosis in transgenic mice.
Biochem Biophys Res Commun. 477:541–547. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu K, Ma L and Zhu J: miR-483-5p promotes
growth, invasion and self-renewal of gastric cancer stem cells by
Wnt/β-catenin signaling. Mol Med Rep. 14:3421–3428. 2016.PubMed/NCBI
|
|
22
|
Xu H, Yang Y, Zhao H, Yang X, Luo Y, Ren
Y, Liu W and Li N: Serum miR-483-5p: A novel diagnostic and
prognostic biomarker for patients with oral squamous cell
carcinoma. Tumour Biol. 37:447–453. 2016. View Article : Google Scholar
|
|
23
|
Qu X, Zhao M, Wu S, Yu W, Xu J, Xu J, Li J
and Chen L: Circulating microRNA 483-5p as a novel biomarker for
diagnosis survival prediction in multiple myeloma. Med Oncol.
31:2192014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song Q, Xu Y, Yang C, Chen Z, Jia C, Chen
J, Zhang Y, Lai P, Fan X, Zhou X, et al: miR-483-5p promotes
invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1
and ALCAM. Cancer Res. 74:3031–3042. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Patel D, Boufraqech M, Jain M, Zhang L, He
M, Gesuwan K, Gulati N, Nilubol N, Fojo T and Kebebew E: MiR-34a
and miR-483-5p are candidate serum biomarkers for adrenocortical
tumors. Surgery. 154:1224–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen J, Wang A, Wang Q, Gurvich I, Siegel
AB, Remotti H and Santella RM: Exploration of genome-wide
circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a
potential biomarker. Cancer Epidemiol Biomarkers Prev.
22:2364–2373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soeda S, Ohyashiki JH, Ohtsuki K, Umezu T,
Setoguchi Y and Ohyashiki K: Clinical relevance of plasma miR-106b
levels in patients with chronic obstructive pulmonary disease. Int
J Mol Med. 31:533–539. 2013.PubMed/NCBI
|
|
28
|
Retamales I, Elliott WM, Meshi B, Coxson
HO, Pare PD, Sciurba FC, Rogers RM, Hayashi S and Hogg JC:
Amplification of inflammation in emphysema and its association with
latent adenoviral infection. Am J Respir Crit Care Med.
164:469–473. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barnes PJ: The cytokine network in asthma
and chronic obstructive pulmonary disease. J Clin Invest.
118:3546–3556. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Grunstein M: Histone acetylation in
chromatin structure and transcription. Nature. 389:349–352. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Laurent GJ: Regulation of lung collagen
production during wound healing. Chest. 99(Suppl 3): 67S–69S. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
de Oliveira MV, Silva PL and Rocco PR:
Animal models of chronic obstructive pulmonary disease. J
Biomedical Sci. 5:12016. View Article : Google Scholar
|
|
33
|
Jaiswal AK: Nrf2 signaling in coordinated
activation of antioxidant gene expression. Free Radic Biol Med.
36:1199–1207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rangasamy T, Cho CY, Thimmulappa RK, Zhen
L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM and
Biswal S: Genetic ablation of Nrf2 enhances susceptibility to
cigarette smoke-induced emphysema in mice. J Clin Invest.
114:1248–1259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Burgess HA, Daugherty LE, Thatcher TH,
Lakatos HF, Ray DM, Redonnet M, Phipps RP and Sime PJ: PPARgamma
agonists inhibit TGF-β induced pulmonary myofibroblast
differentiation and collagen production: Implications for therapy
of lung fibrosis. Am J Physiol Lung Cell Mol Physiol.
288:L1146–L1153. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rotundo RF, Vincent PA, McKeown-Longo PJ,
Blumenstock FA and Saba TM: Hepatic fibronectin matrix turnover in
rats: Involvement of the asialoglycoprotein receptor. Am J Physiol.
277:G1189–G1199. 1999.PubMed/NCBI
|
|
37
|
Chou CW, Zhuo YL, Jiang ZY and Liu YW: The
hemodynamically-regulated vascular microenvironment promotes
migration of the steroidogenic tissue during its interaction with
chromaffin cells in the zebrafish embryo. PLoS One. 9:e1079972014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma X, Yang F, Yang S, Rasul A, Li T, Liu
L, Kong M, Guo D and Ma T: Number and distribution of
myofibroblasts and α-smooth muscle actin expression levels in fetal
membranes with and without gestational complications. Mol Med Rep.
12:2784–2792. 2015.PubMed/NCBI
|
|
39
|
le Rolle AF, Chiu TK, Fara M, Shia J, Zeng
Z, Weiser MR, Paty PB and Chiu VK: The prognostic significance of
CXCL1 hypersecretion by human colorectal cancer epithelia and
myofibroblasts. J Transl Med. 13:1992015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rossi FW, Napolitano F, Pesapane A,
Mascolo M, Staibano S, Matucci-Cerinic M, Guiducci S, Ragno P, di
Spigna G, Postiglione L, et al: Upregulation of the N-formyl
Peptide receptors in scleroderma fibroblasts fosters the switch to
myofibroblasts. J Immunol. 194:5161–5173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiao X, Huang C, Zhao C, Gou X,
Senavirathna LK, Hinsdale M, Lloyd P and Liu L: Regulation of
myofibroblast differentiation by miR-424 during
epithelial-to-mesenchymal transition. Arch Biochem Biophys.
566:49–57. 2015. View Article : Google Scholar :
|
|
42
|
Dey NB, Foley KF, Lincoln TM and Dostmann
WR: Inhibition of cGMP-dependent protein kinase reverses phenotypic
modulation of vascular smooth muscle cells. J Cardiovasc Pharmacol.
45:404–413. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Milara J, Serrano A, Peiró T, Gavaldà A,
Miralpeix M, Morcillo EJ and Cortijo J: Aclidinium inhibits human
lung fibroblast to myofibroblast transition. Thorax. 67:229–237.
2012. View Article : Google Scholar :
|
|
44
|
Löfdahl M, Kaarteenaho R, Lappi-Blanco E,
Tornling G and Sköld MC: Tenascin-C and alpha-smooth muscle actin
positive cells are increased in the large airways in patients with
COPD. Respir Res. 12:482011. View Article : Google Scholar : PubMed/NCBI
|
